Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

A Toll-like receptor 2 genetic variant modulates occurrence of bacterial infections in patients with sickle cell disease.

Tozatto-Maio K, Girot R, Ly ID, Rocha V, Silva Pinto AC, Diagne I, Benzerara Y, Dinardo CL, Kashima S, Leston-Araujo I, Kenzey C, Fonseca GHH, Rodrigues ES, Volt F, Jarduli LR, Ruggeri A, Mariaselvam CM, Gualandro SFM, Elayoubi H, Cunha R, Cappelli B, Malmegrim KCR, Simões BP, Gluckman E, Tamouza R.

Br J Haematol. 2019 Jun;185(5):918-924. doi: 10.1111/bjh.15875. Epub 2019 Mar 25.

PMID:
30908604
2.

Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.

Nguyen-Khoa T, Mine L, Allaf B, Ribeil JA, Remus C, Stanislas A, Gauthereau V, Enouz S, Kim JS, Yang X, Gluckman E, Beaudeux JL, Munnich A, Girot R, Cavazzana M.

Ann Biol Clin (Paris). 2018 Aug 1;76(4):416-420. doi: 10.1684/abc.2018.1354.

PMID:
29976532
3.

[Evidence for the widespread use of neonatal screening for sickle cell disease].

Cavazzana M, Stanislas A, Rémus C, Duwez P, Renoult J, Cretet J, Fernandes S, Le Mée C, Allaf B, Porquet D, Munnich A, Polak M, Gauthereau V, Girot R.

Med Sci (Paris). 2018 Apr;34(4):309-311. doi: 10.1051/medsci/20183404010. Epub 2018 Apr 16. French. No abstract available.

4.

Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.

Haymann JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, Habibi A, Avellino V, Bartolucci P, Benzerara Y, Arlet JB, Djebbar M, Letavernier E, Grateau G, Tabibzadeh N, Girshovich A, Chaignon M, Girot R, Levy P, Lionnet F.

Br J Haematol. 2017 Dec;179(5):820-828. doi: 10.1111/bjh.14969. Epub 2017 Oct 19.

PMID:
29048108
5.

Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks.

Rafii H, Bernaudin F, Rouard H, Vanneaux V, Ruggeri A, Cavazzana M, Gauthereau V, Stanislas A, Benkerrou M, De Montalembert M, Ferry C, Girot R, Arnaud C, Kamdem A, Gour J, Touboul C, Cras A, Kuentz M, Rieux C, Volt F, Cappelli B, Maio KT, Paviglianiti A, Kenzey C, Larghero J, Gluckman E.

Haematologica. 2017 Jun;102(6):976-983. doi: 10.3324/haematol.2016.163055. Epub 2017 Mar 16.

6.

Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort study.

Senet P, Blas-Chatelain C, Levy P, Manea EM, Peschanski M, Mirault T, Stankovic-Stojanovic K, Debure C, Debbache K, Girot R, Bureau JM, Bachmeyer C, Baldeschi C, Galacteros F, Lionnet F, Gellen-Dautremer J.

Br J Dermatol. 2017 Jul;177(1):206-211. doi: 10.1111/bjd.15241. Epub 2017 Apr 26.

PMID:
27992062
7.

Iron restriction is an important treatment of hemoglobin SC disease.

Lionnet F, Hammoudi N, Stojanovic KS, Avellino V, Grateau G, Girot R, Haymann JP.

Am J Hematol. 2016 Jul;91(7):E320. doi: 10.1002/ajh.24380. Epub 2016 Apr 24. No abstract available.

8.

Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow.

Garraud O, Heshmati F, Pozzetto B, Lefrere F, Girot R, Saillol A, Laperche S.

Transfus Clin Biol. 2016 Feb;23(1):39-44. doi: 10.1016/j.tracli.2015.12.003. Epub 2016 Jan 6. Review.

PMID:
26775794
9.

Maternal mortality among women with sickle-cell disease in France, 1996-2009.

Lesage N, Deneux Tharaux C, Saucedo M, Habibi A, Galacteros F, Girot R, Bouvier Colle MH, Kayem G.

Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:183-8. doi: 10.1016/j.ejogrb.2015.09.016. Epub 2015 Sep 25.

PMID:
26431903
10.

Facial lesions heralding the onset and relapse of eosinophilic fasciitis.

Bachmeyer C, Moguelet P, Rein C, Girot R.

Clin Exp Dermatol. 2016 Jun;41(4):456-7. doi: 10.1111/ced.12760. Epub 2015 Sep 7. No abstract available.

PMID:
26344940
11.

Prophylactic laparoscopic cholecystectomy in adult sickle cell disease patients with cholelithiasis: A prospective cohort study.

Muroni M, Loi V, Lionnet F, Girot R, Houry S.

Int J Surg. 2015 Oct;22:62-6. doi: 10.1016/j.ijsu.2015.07.708. Epub 2015 Aug 14.

12.

[The impact of screening sickle-cell carriers in the general population. A retrospective study in the Paris screening center].

Lainé A, Bardakdjian J, Prunelle F, Maroja FE, Quélet S, Girot R, Niakaté A.

Rev Epidemiol Sante Publique. 2015 Apr;63(2):77-84. doi: 10.1016/j.respe.2015.02.022. Epub 2015 Mar 26. French.

PMID:
25819994
13.

Left atrial volume is not an index of left ventricular diastolic dysfunction in patients with sickle cell anaemia.

Hammoudi N, Charbonnier M, Levy P, Djebbar M, Stankovic Stojanovic K, Ederhy S, Girot R, Cohen A, Isnard R, Lionnet F.

Arch Cardiovasc Dis. 2015 Mar;108(3):156-62. doi: 10.1016/j.acvd.2014.09.010. Epub 2015 Feb 7.

14.

Subclinical left ventricular systolic impairment in steady state young adult patients with sickle-cell anemia.

Hammoudi N, Arangalage D, Djebbar M, Stojanovic KS, Charbonnier M, Isnard R, Girot R, Michel PL, Lionnet F.

Int J Cardiovasc Imaging. 2014 Oct;30(7):1297-304. doi: 10.1007/s10554-014-0473-1. Epub 2014 Jun 22.

15.

Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center.

Gueguen A, Mahevas M, Nzouakou R, Hosseini H, Habibi A, Bachir D, Brugière P, Lionnet F, Ribei JA, Godeau B, Girot R, Ibrahima V, Calvet D, Galactéros F, Bartolucci P.

Am J Hematol. 2014 Mar;89(3):267-72.

16.

Outcomes of adult patients with sickle cell disease admitted to the ICU: a case series*.

Cecchini J, Lionnet F, Djibré M, Parrot A, Stojanovic KS, Girot R, Fartoukh M.

Crit Care Med. 2014 Jul;42(7):1629-39. doi: 10.1097/CCM.0000000000000316.

PMID:
24674925
17.

Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease.

Maurel S, Stankovic Stojanovic K, Avellino V, Girshovich A, Letavernier E, Grateau G, Baud L, Girot R, Lionnet F, Haymann JP.

Clin J Am Soc Nephrol. 2014 Apr;9(4):648-53. doi: 10.2215/CJN.09790913. Epub 2014 Jan 23.

18.

The association of CD81 polymorphisms with alloimmunization in sickle cell disease.

Tatari-Calderone Z, Tamouza R, Le Bouder GP, Dewan R, Luban NL, Lasserre J, Maury J, Lionnet F, Krishnamoorthy R, Girot R, Vukmanovic S.

Clin Dev Immunol. 2013;2013:937846. doi: 10.1155/2013/937846. Epub 2013 May 22.

19.

High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients.

Stankovic Stojanovic K, Steichen O, Lefevre G, Bachmeyer C, Avellino V, Grateau G, Girot R, Lionnet F.

Clin Biochem. 2012 Dec;45(18):1578-82. doi: 10.1016/j.clinbiochem.2012.07.114. Epub 2012 Aug 8.

PMID:
22892192
20.

The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.

Gerotziafas GT, Van Dreden P, Chaari M, Galea V, Khaterchi A, Lionnet F, Stankovic-Stojanovic K, Blanc-Brude O, Woodhams B, Maier-Redelsperger M, Girot R, Hatmi M, Elalamy I.

Thromb Haemost. 2012 Jun;107(6):1044-52. doi: 10.1160/TH11-10-0689. Epub 2012 Apr 26.

PMID:
22535498
21.

Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Lionnet F, Hammoudi N, Stojanovic KS, Avellino V, Grateau G, Girot R, Haymann JP.

Haematologica. 2012 Aug;97(8):1136-41. doi: 10.3324/haematol.2011.055202. Epub 2012 Feb 7.

22.

Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity.

Abuaf N, Rostane H, Barbara J, Toly-Ndour C, Gaouar H, Mathelier-Fusade P, Leynadier F, Francès C, Girot R.

J Allergy (Cairo). 2012;2012:580873. doi: 10.1155/2012/580873. Epub 2011 Dec 1.

23.

A hemodynamic study of pulmonary hypertension in sickle cell disease.

Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G.

N Engl J Med. 2011 Jul 7;365(1):44-53. doi: 10.1056/NEJMoa1005565.

24.

The risk of going abroad in sickle cell disease: a study of 148 adults.

Stankovic Stojanovic K, Lionnet F, Girot R, Lescure FX, Pialoux G, Le Loup G.

Trans R Soc Trop Med Hyg. 2011 Jun;105(6):310-4. doi: 10.1016/j.trstmh.2011.02.005. Epub 2011 Apr 2.

PMID:
21459395
25.

Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations.

Ducamp S, Kannengiesser C, Touati M, Garçon L, Guerci-Bresler A, Guichard JF, Vermylen C, Dochir J, Poirel HA, Fouyssac F, Mansuy L, Leroux G, Tertian G, Girot R, Heimpel H, Matthes T, Talbi N, Deybach JC, Beaumont C, Puy H, Grandchamp B.

Hum Mutat. 2011 Jun;32(6):590-7. doi: 10.1002/humu.21455. Epub 2011 Feb 24.

PMID:
21309041
26.

Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis?

Stankovic Stojanovic K, Steichen O, Lionnet F, Bachmeyer C, Lecomte I, Avellino V, Grateau G, Girot R, Lefevre G.

Infection. 2011 Feb;39(1):41-5. doi: 10.1007/s15010-010-0072-6. Epub 2011 Jan 11.

PMID:
21221702
27.

Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.

Nzouakou R, Bachir D, Lavaud A, Habibi A, Lee K, Lionnet F, Hulin A, Jouault H, Préhu C, Roudot-Thoraval F, Girot R, Galactéros F.

Acta Haematol. 2011;125(3):145-52. doi: 10.1159/000322248. Epub 2010 Dec 24.

PMID:
21196716
28.

High titers of autoantibodies in patients with sickle-cell disease.

Toly-Ndour C, Rouquette AM, Obadia S, M'bappe P, Lionnet F, Hagege I, Boussa-Khettab F, Tshilolo L, Girot R.

J Rheumatol. 2011 Feb;38(2):302-9. doi: 10.3899/jrheum.100667. Epub 2010 Dec 1.

PMID:
21123321
29.

Coenzyme Q is effective on anemia in a patient with sideroblastic anemia and mitochondrial myopathy.

Bachmeyer C, Ferroir JP, Eymard B, Maïer-Redelsperger M, Lebre AS, Girot R.

Blood. 2010 Nov 4;116(18):3681-2. doi: 10.1182/blood-2010-07-299453. No abstract available.

PMID:
21051567
30.

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chrétien L, Bernaudin F, Girot R, Dorazio R, Mulder GJ, Polack A, Bank A, Soulier J, Larghero J, Kabbara N, Dalle B, Gourmel B, Socie G, Chrétien S, Cartier N, Aubourg P, Fischer A, Cornetta K, Galacteros F, Beuzard Y, Gluckman E, Bushman F, Hacein-Bey-Abina S, Leboulch P.

Nature. 2010 Sep 16;467(7313):318-22. doi: 10.1038/nature09328.

31.

Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia.

Maier-Redelsperger M, Lévy P, Lionnet F, Stankovic K, Haymann JP, Lefèvre G, Avellino V, Perol JP, Girot R, Elion J.

Blood Cells Mol Dis. 2010 Dec 15;45(4):289-92. doi: 10.1016/j.bcmd.2010.08.001. Epub 2010 Sep 15.

PMID:
20833087
32.

Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature.

Haymann JP, Stankovic K, Levy P, Avellino V, Tharaux PL, Letavernier E, Grateau G, Baud L, Girot R, Lionnet F.

Clin J Am Soc Nephrol. 2010 May;5(5):756-61. doi: 10.2215/CJN.08511109. Epub 2010 Feb 25.

33.

Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia.

Bachmeyer C, Maury J, Parrot A, Bachir D, Stankovic K, Girot R, Lionnet F.

Am J Hematol. 2010 Jan;85(1):91-2. doi: 10.1002/ajh.21578. No abstract available.

34.

Complications and treatment of patients with β-thalassemia in France: results of the National Registry.

Thuret I, Pondarré C, Loundou A, Steschenko D, Girot R, Bachir D, Rose C, Barlogis V, Donadieu J, de Montalembert M, Hagege I, Pegourie B, Berger C, Micheau M, Bernaudin F, Leblanc T, Lutz L, Galactéros F, Siméoni MC, Badens C.

Haematologica. 2010 May;95(5):724-9. doi: 10.3324/haematol.2009.018051. Epub 2009 Dec 8.

35.

Human parvovirus 4 in recipients of cellular products and in blood donors: epidemiologic similarity with B19 parvovirus.

Servant-Delmas A, Laperche S, Mercier M, Elghouzzi MH, Lionnet F, Stankovic K, Girot R, Lefrère JJ.

Transfusion. 2009 Aug;49(8):1771-3. doi: 10.1111/j.1537-2995.2009.02286.x. No abstract available.

PMID:
19732407
36.

[New issues in adult sickle sell disease].

Girot R, Stankovic K, Lionnet F.

Bull Acad Natl Med. 2008 Oct;192(7):1395-409; discussion 1409-11. Review. French.

PMID:
19445365
37.

Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.

Ancel D, Amiot X, Chaslin-Ferbus D, Hagege I, Garioud A, Girot R, Pol S, Grange JD.

Eur J Gastroenterol Hepatol. 2009 Jul;21(7):726-9. doi: 10.1097/MEG.0b013e3283097699.

PMID:
19404206
38.

Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease?

Brousse V, Hertz-Pannier L, Consigny Y, Bresson JL, Girot R, Mirre E, Lenoir G, de Montalembert M.

Ann Hematol. 2009 Aug;88(8):785-8. doi: 10.1007/s00277-008-0670-x. Epub 2008 Dec 24.

PMID:
19107481
39.

Idiopathic pulmonary arterial hypertension in a patient with pyruvate kinase deficiency and paravertebral extramedullary hematopoiesis.

Bachmeyer C, Khalil A, Kerrou K, Girot R, Gounant V.

Ann Hematol. 2009 Jun;88(6):603-5. doi: 10.1007/s00277-008-0644-z. Epub 2008 Nov 29. No abstract available.

PMID:
19039535
40.

Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers.

Lionnet F, Bachmeyer C, Stankovic K, Tharaux PL, Girot R, Aractingi S.

Br J Haematol. 2008 Sep;142(6):991-2. doi: 10.1111/j.1365-2141.2008.07206.x. Epub 2008 Jul 29. No abstract available.

PMID:
18671710
41.

Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males.

Berthaut I, Guignedoux G, Kirsch-Noir F, de Larouziere V, Ravel C, Bachir D, Galactéros F, Ancel PY, Kunstmann JM, Levy L, Jouannet P, Girot R, Mandelbaum J.

Haematologica. 2008 Jul;93(7):988-93. doi: 10.3324/haematol.11515. Epub 2008 May 27.

42.

Healing of sickle cell ulcers during pregnancy: a favourable effect of foetal cell transfer?

Droitcourt C, Khosrotehrani K, Girot R, Aractingi S.

J Eur Acad Dermatol Venereol. 2008 Nov;22(10):1256-7. doi: 10.1111/j.1468-3083.2008.02602.x. Epub 2008 Apr 22. No abstract available.

PMID:
18429979
43.

Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Sabaa N, de Franceschi L, Bonnin P, Castier Y, Malpeli G, Debbabi H, Galaup A, Maier-Redelsperger M, Vandermeersch S, Scarpa A, Janin A, Levy B, Girot R, Beuzard Y, Leboeuf C, Henri A, Germain S, Dussaule JC, Tharaux PL.

J Clin Invest. 2008 May;118(5):1924-33. doi: 10.1172/JCI33308.

44.

Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy.

Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F, Girot R.

Clin Exp Allergy. 2008 Jun;38(6):921-8. doi: 10.1111/j.1365-2222.2008.02960.x. Epub 2008 Mar 6.

PMID:
18331364
45.

Repository of blood samples from recipients of red blood cell transfusions in France.

Lefrère JJ, Laperche S, Girot R.

Transfusion. 2008 Jan;48(1):195; author reply 195-6. doi: 10.1111/j.1537-2995.2007.01560.x. No abstract available.

PMID:
18184237
46.

Sickle cell leg ulcers: a frequently disabling complication and a marker of severity.

Halabi-Tawil M, Lionnet F, Girot R, Bachmeyer C, Lévy PP, Aractingi S.

Br J Dermatol. 2008 Feb;158(2):339-44. Epub 2007 Nov 28.

PMID:
18047512
47.

HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia.

Tamouza R, Busson M, Fortier C, Diagne I, Diallo D, Sloma I, Contouris H, Krishnamoorthy R, Labie D, Girot R, Charron D.

Hum Immunol. 2007 Oct;68(10):849-53. Epub 2007 Sep 19.

PMID:
17961774
48.

Tuberculosis in adult patients with sickle cell disease.

Lionnet F, Bachmeyer C, Sloma I, Rossier A, Thioliere B, Maier M, Grateau G, Girot R, Cadranel J.

J Infect. 2007 Nov;55(5):439-44. Epub 2007 Aug 22.

PMID:
17714789
49.

Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia.

Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, Lai ME, Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S, Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF.

Clin Ther. 2007 May;29(5):909-917. doi: 10.1016/j.clinthera.2007.05.007.

PMID:
17697909
50.

[Sickle cell disease: from childhood to adult age].

Girot R, Lionnet F.

Arch Pediatr. 2007 Jun;14(6):605-6. Epub 2007 Mar 27. French. No abstract available.

PMID:
17391938

Supplemental Content

Support Center